Thus, it has been proposed that P2X7 receptor inhibition functions as a therapeutic strategy to dampen neuroinflammation, consequently decreasing neurodegeneration, especially in AD, PD and MS. The gene discussed is P2RX7; the disease is Alzheimer disease.